Programa
Thursday, November 21st
08:15
Early stage disease in the last 5cm of the rectum
Moderator: Rodrigo Oliva Perez
Advanced endoscopic assessment - What are the ideal selection criteria for an ESD
Fauze Maluf
MR can provide useful/objective criteria for the selection of patients for local excision
Gina Brown
Early Rectal Cancer
Why full-thickness local excision is better than ESD?
Fraser Smith
Why ESD is better than FTLE?
Fauze Maluf
“Unfavorable” T1 distal rectal cancer
Contact RT is better than surgery
Jean Pierre Gerard
TME is still the best treatment
Albert Wolthuis
Discussion
09:40
Special Lecture I: Rectal Cancer - What are the patients that need lateral node dissection?
Miranda Kusters
10:00
Coffee-Break
11:00
Tricks of the trade: Videos with no “BS”...
Moderator: Sérgio Araujo
Transanal TME - How to get into the correct plane earlier in very distal cancers?
Joep Knol
Intersphincteric dissection upside down!
Joep Knol
Robotic TME - How is the robot better than lap in the obese male?
Julio Garcia Aguilar
Robotic TME - Salvage TME after a local regrowth - Is it more difficult than for a primary rectal cancer?
Nuno Figueiredo
Laparoscopic lateral node dissection - Step by Step
Guilherme Pagin São Julião
Extralevator APR - Doing it from above with the robot
Slawomir Marecik
Extralevator APR - Doing it from below with the transanal platform
Joep Knol
Simple Extralevator APR - Good open surgery from below...
Bruna Vailati
12:00
Satellite Symposium 1 Intraoperative and Postoperative Complications in Colorectal Surgery Interactive Case Discussion
14:00
Modern Neoadjuvant Treatment
Moderator: Carlos Carvalho
Chemo first
Total Neoadjuvant Therapy: new kid on the block
Andrea Cercek
Radiation first
Short-course RT and consolidation chemotherapy - Improving survival in rectal cancer?
Krzysztof Bujko
Organ-preservation - Why contact RT after standard external CRT is the best strategy for achieving a sustained complete response?
Jean Pierre Gerard
Induction Chemotherapy in order to tailor treatment of rectal cancer - The French Experience
Eric Rullier
Discussion
15:00
Coffee-Break
16:00
Assessment of tumor response to CRT
Moderator: Fraser Smith
mrTRG is critical for decision management
Gina Brown
The (in)consistency of clinical assessment
Julio Garcia Aguilar
Radiomics - What is it and how this may be relevant for the management of rectal cancer patients?
Cinthia Ortega
PET-MR - Is there a role in systemic or locorregional staging?
Carlos Buchpiguel
Discussion
17:15
MDT - Real case discussion in rectal cancer
Moderator: Rodrigo Perez
Geerard Beets
Eric Rullier
Slawomir Marecik
Gina Brown
Jean Pierre Gerard
Eduardo de Santibañes
Friday, November 22nd
08:00
Controversial issues in rectal cancer
Moderator: Geerard Beets
Salvage after a local regrowth
Nuno Figueiredo
pCRM+ after proper TME - then what?
Quentin Denost
Upper rectal cancer - are we doing a good job as surgeons with partial TME?
Soren Laurberg
No more loop ileostomies in rectal cancer after TME?
Pieter Tanis
How bad are the functional outcomes after TME even in the absence of nCRT? Lessons learned with the LARS score
Therese Juul
Conditional survival after WW - What are the risk factors for local regrowth over time
Laura Fernandez
Discussion
10:00
Coffee-break
10:30
Mechanisms of invasion and advanced disease
Moderator: Carlos Carvalho
The (Ir) relevance of the metastatic lymph nodes in rectal cancer
Iris Nagtegaal
Locally advanced disease - what are the technical/surgical limits for pelvic exenteration?
Quentin Denost
The pathological and clinical significance of tumor deposits - What they are and what do they mean?
Iris Nagtegaal
Adjuvant therapy after nCRT in rectal cancer - What, when and for how long?
Eric Van Cutsem
Synchronous unresectable metastatic rectal cancer - Do we have to worry about the primary?
Josh Smith
Discussion
12:00
Satellite Symposium Extended lymph node dissection in colorectal cancer using minimally invasive approaches
Moderator: Guilherme Pagin São julião
Central vascular ligation in proximal colon cancer - Definition, Rationale and who benefits from it?
Pieter Tanis
Laparoscopic optimal D2 lymphadenectomy for right colon cancer - step by step
Albert Wolthuis
Robotic right colectomy - Is it better than lap?
Slawomir Marecik
Robotic D3/CME for right colon cancer - How I do it
Julio Garcia Aguilar
Case Discussion
Bruna Vailati
14:00
Organ-preservation Near-complete response after nCRT
Moderator: Albert Wolthuis
Definition of what a good (but incomplete) response is ...
Nuno Figueiredo
Give it more time or more (contact) RT?
Geerard Beets
Just locally excise it!
Fraser Smith
Give it more chemotherapy - Is there a role for consolidation chemotherapy?
Andrea Cercek
Funtional outcomes after WW - Is it perfect?
Geerard Beets
Discussion
15:30
Special Lecture: The Watch and Wait Story so far...
Angelita Habr-Gama
16:00
Coffee-break
16:30
Advanced disease
Moderator: Quentin Denost
Intraperitonial rectal cancer invading the peritonial surface (T4a) - Is there a role for prophylactic HIPEC?
Pieter Tanis
Potentially resectable metastatic disease and locally advanced rectal cancer
Chemotherapy alone is the preferred primary approach!
Andrea Cercek
Is there a place for stents in the rectum?
Pieter Tanis
When short-course followed by chemo is the best alternative upfront
Krzysztof Bujko
Is there a place for synchronous liver and rectum resection - When and how?
Eduardo De Santibanes
Discussion
18:00
Special Lecture: Rectal Cancer. From open TME to no surgery... What has been real and what is rubbish in rectal cancer management in the last 50 years - The master’s view
Bill Heald
Saturday, November 23rd
08:00
Terrifying Videos
Armando Melani
Things that may go wrong... and how to fix them!
Oncological problems with taTME...
Albert Wolthuis
During Robotic TME.
Slawomir Marecik
During pelvic exenteration.
Quentin Denost
Technical problems during taTME.
Joep Knol
Discussion
09:00
Multidisciplinary approach to rectal cancer. Case discussion.
Moderator: Rodrigo Perez
Panel:
Eric Van Cutsem
Fabio Kater
Thiago Jorge
Ricardo Carvalho
Robson Ferrigno
Geerard Beets
10:00
Coffee break
10:30
Ultimate challenges
Moderator: Geerard Beets
7 vs 11 weeks after nCRT - The latest from Greccar 6
Eric Rullier
6 vs 12 weeks - The longer the better...
Gina Brown
Discussion
11:15
Molecular biology for the future management of rectal cancer
Moderator: Carlos Carvalho
Using rectal cancer tumoroids to test for chemo and radiation sensitivity / resistance
Josh Smith
Prediction of response - Are we anywhere near a clinically useful tool?
Julio Garcia Aguilar
Current guidelines and Future Clinical practice - How I think rectal cancer should be treated in 2030
Eric Van Cutsem
12:00
Closing remarks
